Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions

202333 citationsJournal Article

Authors

Mathieu Uzzan · Université Paris-Est Créteil

Yoram Bouhnik · Clinique Hartmann

María T. Abreu · Crohn's and Colitis Foundation

Harris A Ahmad · Bristol-Myers Squibb (United States)

Shashi Adsul · Takeda (Switzerland)

Hilde Carlier

Marla Dubinsky · Icahn School of Medicine at Mount Sinai

Abstract

This joint effort is proposed as the basis for profound clinical trial transformation triggered by investigative centres, contract research organizations, sponsors and regulatory agencies.

Topics & Keywords

Inflammatory Bowel Disease Biosimilars and Bioanalytical Methods Microscopic Colitis

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Journal of Crohn s and Colitis

Volume 17, Issue 7, pp. 1066-1078

DOI: 10.1093/ecco-jcc/jjad020

Field-Weighted Citation Impact: 10.39